| 中文名称 | 4,4'-二甲氧基苯酚酯 |
| 英文名称 | 4,4'-DIMETHOXYBENZIL |
| CAS号 | 1226-42-2 |
| 分子式 | C16H14O4 |
| 分子量 | 270.28 |
| EINECS号 | 214-960-5 |
| 熔点 | 132-134 °C(lit.) |
| 沸点 | 373.4°C (rough estimate) |
| 密度 | 1.2117 (rough estimate) |
| 折射率 | 1.5447 (estimate) |
| 溶解度 | DMSO:50 mg/mL (184.99 mM);水:< 0.1 mg/mL(不溶) |
| 形态 | 精细结晶粉末 |
| 颜色 | 粘黄色 |
| 水溶解性 | Insoluble in water. |
| BRN | 531345 |
| 危险品标志 | Xi |
| 危险类别码 | 36/37/38 |
| 安全说明 | 22-24/25-36/37-26 |
| WGK Germany | 3 |
| TSCA | Yes |
| 海关编码 | 29145090 |
Ki: 70 nM ( hiCE )
By reducing irinotecaninduced diarrhea, hiCE inhibitors (e.g., 4,4'-Dimethoxybenzil, Compound 8) can improve the anti-cancer efficacy of irinotecan. To find effective hiCE inhibitors, a new virtual screening protocol that combines pharmacophore models derived from the hiCE structure and its ligands has been proposed.